Microbix Biosystems Stock Today
| MBX Stock | CAD 0.23 0.01 4.55% |
PerformanceWeakest
| Odds Of DistressFair
|
Microbix Biosystems is selling at 0.23 as of the 11th of February 2026; that is 4.55% up since the beginning of the trading day. The stock's open price was 0.22. Microbix Biosystems has 48 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 13th of November 2025 and ending today, the 11th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada.. The company has 138.81 M outstanding shares of which 2.58 K shares are now shorted by private and institutional investors with about 0.19 days to cover all short positions. More on Microbix Biosystems
Moving together with Microbix Stock
Moving against Microbix Stock
Microbix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Microbix Biosystems' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Microbix Biosystems or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Cameron Groome | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Microbix Biosystems' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Microbix Biosystems' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMicrobix Biosystems utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Microbix Biosystems' leverage profile, showing how much of Microbix Biosystems' resources are funded through borrowing.
| |||||
Microbix Biosystems (MBX) is traded on Toronto Exchange in Canada and employs 15 people. Microbix Biosystems is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbix Biosystems's market, we take the total number of its shares issued and multiply it by Microbix Biosystems's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Microbix Biosystems operates under Biotechnology sector and is part of Health Care industry. The entity has 138.81 M outstanding shares of which 2.58 K shares are now shorted by private and institutional investors with about 0.19 days to cover all short positions.
Microbix Biosystems has accumulated about 402.12 K in cash with (80.29 K) of positive cash flow from operations.
Check Microbix Biosystems Probability Of Bankruptcy
Ownership AllocationMicrobix Biosystems maintains a total of 138.81 Million outstanding shares. Microbix Biosystems secures 14.5 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Microbix Ownership Details
Microbix Biosystems Historical Income Statement
Microbix Stock Against Markets
Microbix Stock Analysis Notes
About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Microbix Biosystems recorded a loss per share of 0.02. The entity last dividend was issued on the 2nd of September 1999. Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada. To find out more about Microbix Biosystems contact Cameron Groome at 905 361 8910 or learn more at https://www.microbix.com.Microbix Biosystems Quarterly Total Revenue |
|
Microbix Biosystems Investment Alerts
| Microbix Biosystems generated a negative expected return over the last 90 days | |
| Microbix Biosystems has some characteristics of a very speculative penny stock | |
| Microbix Biosystems has high historical volatility and very poor performance | |
| The company reported the revenue of 18.59 M. Net Loss for the year was (2.25 M) with profit before overhead, payroll, taxes, and interest of 9.85 M. | |
| Microbix Biosystems has accumulated about 402.12 K in cash with (80.29 K) of positive cash flow from operations. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Microbix to Release Q1 2026 Results and Host Investor Webinar on February 12 - TipRanks |
Microbix Largest EPS Surprises
Earnings surprises can significantly impact Microbix Biosystems' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-08-11 | 2022-06-30 | 0.01 | 0.0045 | -0.0055 | 55 | ||
2023-05-11 | 2023-03-31 | 0.01 | 2.0E-4 | -0.0098 | 98 | ||
2023-08-10 | 2023-06-30 | 0.01 | -0.01 | -0.02 | 200 |
Microbix Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbix Biosystems's market, we take the total number of its shares issued and multiply it by Microbix Biosystems's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Microbix Profitablity
Microbix Biosystems' profitability indicators refer to fundamental financial ratios that showcase Microbix Biosystems' ability to generate income relative to its revenue or operating costs. If, let's say, Microbix Biosystems is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Microbix Biosystems' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Microbix Biosystems' profitability requires more research than a typical breakdown of Microbix Biosystems' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.38. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.05) | (0.06) | |
| Return On Equity | (0.07) | (0.08) |
Management Efficiency
Microbix Biosystems has return on total asset (ROA) of (0.0261) % which means that it has lost $0.0261 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0801) %, meaning that it generated substantial loss on money invested by shareholders. Microbix Biosystems' management efficiency ratios could be used to measure how well Microbix Biosystems manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of February 2026, Return On Tangible Assets is likely to drop to -0.06. In addition to that, Return On Capital Employed is likely to drop to -0.04. At this time, Microbix Biosystems' Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.18 | 0.10 | |
| Tangible Book Value Per Share | 0.17 | 0.16 | |
| Enterprise Value Over EBITDA | 84.69 | 88.93 | |
| Price Book Value Ratio | 1.53 | 1.45 | |
| Enterprise Value Multiple | 84.69 | 88.93 | |
| Price Fair Value | 1.53 | 1.45 | |
| Enterprise Value | 28.4 M | 24.5 M |
Leadership effectiveness at Microbix Biosystems is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 11th of February 2026, Microbix Biosystems secures the Mean Deviation of 2.31, standard deviation of 3.42, and Risk Adjusted Performance of (0.01). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Microbix Biosystems, as well as the relationship between them.Microbix Biosystems Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Microbix Biosystems Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Microbix Biosystems price patterns.
Microbix Biosystems Outstanding Bonds
Microbix Biosystems issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Microbix Biosystems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Microbix bonds can be classified according to their maturity, which is the date when Microbix Biosystems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Microbix Biosystems Predictive Daily Indicators
Microbix Biosystems intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Microbix Biosystems stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 4112.8 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 0.24 | |||
| Day Typical Price | 0.24 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | 0.01 |
Microbix Biosystems Forecast Models
Microbix Biosystems' time-series forecasting models are one of many Microbix Biosystems' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Microbix Biosystems' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Microbix Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Microbix Biosystems Corporate Executives
Elected by the shareholders, the Microbix Biosystems' board of directors comprises two types of representatives: Microbix Biosystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbix. The board's role is to monitor Microbix Biosystems' management team and ensure that shareholders' interests are well served. Microbix Biosystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbix Biosystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Currie | Chief Financial Officer | Profile | |
| Kenneth Hughes | Chief Operating Officer | Profile |
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.